Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer

Li Jen Cheng, Grace Wong, Wen Yee Chay, Joanne Ngeow, Yongqiang Tan, Swee Sung Soon, Mohamed Ismail Abdul Aziz, Fiona Pearce, Kwong Ng*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry